International Seminar: “Antigen cross presentation in mouse and human dendritic cells”30/12/2016
The generation of the Vesicle Trafficking Protein Sec22b-defective mice allowed us to address the role of antigen cross presentation in vivo, including during anti tumor immune responses induced by anti-PD-1 therapy. Conversely, enhancing antigen presentation pharmacologically can promote checkpoint therapy in pre-clinical tumor models.
Sebastián Amigorena, PhD
INSERM U932, Immunité et Cancer
Wednesday, January 4th, 2017
Fundación Ciencia & Vida
Avenida Zañartu 1482, Ñuñoa, Santiago